Morphine Sulfate Tablet, Extended Release
Product Images NDC 0406-8380

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0406-8380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed M (Morphine Sulfate Er 1)

FDA Label Image

Boxed M (Morphine Sulfate Er 10)

FDA Label Image

Boxed M (Morphine Sulfate Er 11)

FDA Label Image

Principal Display Panel (15 mg)

This is a medication description for Morphine Sulfate extended-release tablets. It comes in a bottle with the NDC code 0406-8315-01 and contains 100 tablets. The usual adult dosage is not specified and it suggests referring to the complete dosage information on the package. The tablets should not be broken, crushed, dissolved, or chewed. The storage requirement is between 20° to 25°C (68" to 77°F). The information for pediatric use is not clear, and it is advisable to read the medication guide provided separately for each patient by the pharmacist. The text also includes manufacturer information for the drug produced by Mallinckrodt, located in Webster Groves, Missouri.*

FDA Label Image

Principal Display Panel (30 mg)

NDC 0406-8330-01 is a package of 100 extended-release Morphine Sulfate tablets. The usual adult dosage is not available. The tablets should be stored between 20° and 25°C (66° and 77°F) and dispensed in a light-resistant container with a child-resistant closure. Each tablet contains 30mg of Morphine Sulfate USP. The medication guide is provided separately to each patient. The product is manufactured by Mallinckrodt and distributed by WebstorGroves in Missouri, USA.*

FDA Label Image

Principal Display Panel (60 mg)

The text provides information on a medication, specifically Morphine Sulfate C Extended-Release Tablets. The tablets contain Morphine Sufate USP and are meant for adult use only. The recommended dosage and storage instructions are provided along with a warning to dispense the medication guide to patients. It is necessary to store the medication in a controlled room with certain requirements. The manufacturer is Mallinckrodt™.*

FDA Label Image

Principal Display Panel (100 mg)

NDC 0406-8390-01 is a prescription drug used to relieve pain. The package contains 100 tablets and recommended for adults. Morphine sulfate is the active ingredient and dosage information can be found inside the package. The tablets should be swallowed whole and not be crushed, dissolved, or chewed. The drug must be stored at 20-25℃ in a tightly sealed container with a child-resistant closure. The pharmacist must dispense the medication guide to the patient and must not accept if the seal over the bottle or packaging is broken or missing.*

FDA Label Image

Principal Display Panel (200 mg)

This is a description of a medication with NDC 0406-8320-01. The medication is in tablet form, containing Morphine Sulfate USP with a dosage of 200 mg. The tablets are extended-release and should not be broken, crushed, dissolved or chewed. The usual adult dosage is not specified and should be consulted from the package insert. The tablets should be stored at 20" to 25°C (68° to 77°F) in a light-resistant container with a child-resistant closure. The Medication Guide should be provided by the pharmacist separately to each patient. The manufacturer appears to be SpecGx LLC, located in Webster Groves, MO.*

FDA Label Image

Boxed M (Morphine Sulfate Er 2)

FDA Label Image

Boxed M (Morphine Sulfate Er 3)

FDA Label Image

Boxed M (Morphine Sulfate Er 4)

FDA Label Image

Boxed M (Morphine Sulfate Er 5)

FDA Label Image

Morphinesulfatestructure (Morphine Sulfate Er 6)

This appears to be a chemical formula for a compound, namely C17H16NO3, and some additional information about its molecular weight and possibly its physical state. However, without further context or information, it is not possible to determine what the compound is or what its properties or uses might be.*

FDA Label Image

Boxed M (Morphine Sulfate Er 7)

FDA Label Image

Boxed M (Morphine Sulfate Er 8)

FDA Label Image

Boxed M (Morphine Sulfate Er 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.